LP
LEXICON PHARMACEUTICALS, INC.
SEC filingPharmaceuticals · The Woodlands, TX
Amount raised$55.7Msold at filing
Total offering$59.2M$3.5M still open
Investors in the raise1count reported to the SEC
FiledFeb 17, 2026first sale Feb 2, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Christopher E. SobeckiDirector
Judith L. SwainDirector
Raymond DebbaneDirector
Brian T. CrumExecutive Officer
Rachel B. MartensExecutive Officer
Scott H. CoianteExecutive Officer
Rachel T. MartensExecutive Officer
Samuel J. BarkerDirector
Craig B. GranowitzExecutive Officer
Ivan H. CheungDirector
Wendy E. McDermottExecutive Officer
Lisa T. DeFrancescoExecutive Officer
Executive officers, directors and promoters as listed on the Form D.